Skip to main content
Erschienen in: The Journal of Headache and Pain 1/2014

Open Access 01.12.2014 | Meeting abstract

EHMTI-0318. The place of corticosteroids in migraine attack management: systematic review and critical appraisal

verfasst von: YW Woldeamanuel, AM Rapoport, RP Cowan

Erschienen in: The Journal of Headache and Pain | Sonderheft 1/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Introduction

Headaches recur in up to 87% of migraine patients visiting the emergency department (ED), making ED recidivism a management challenge.

Aims

We aimed herein to determine the role of corticosteroids in the acute management of migraine in the ED and outpatient care.

Methods

A PubMed search was employed for Clinical Studies and Systematic Reviews on the PubMed Clinical Queries tool combining the terms ‘migraine’ and ‘corticosteroids’ from 1980 until May 1, 2014.

Results

Twenty-two studies (n=2203, 50% ED-based, 64% randomized-controlled) and four systematic reviews were included. International Classification of Headache Disorders criteria were applied in 68%. Twenty-one studies indicated observed outcome differences favoring benefits of corticosteroid administration. Median absolute risk reduction was 30% (range 6 - 48.2%) and 11% (6 - 48.6%) for 24- and 72-hour headache recurrence, respectively. Parenteral dexamethasone was the most commonly (65%) administered steroid, at an average single dose of 12.8 mg (range 4 - 24 mg). All meta-analyses revealed efficacy of adjuvant corticosteroids to various abortive medications – indicating generalizability. Adverse effects were tolerable. Higher disability, status migrainosus, incomplete pain relief, and previous history of headache recurrence predicted outcome favourability.

Conclusions

Our literature review suggests that with corticosteroid treatment, recurrent headaches become milder than pretreated headaches and later respond to nonsteroidal therapy. Single-dose intravenous dexamethasone provides reasonable option for managing resistant, severe, or prolonged migraine attacks; recommendations include 6-8 administrations per year with follow up of adverse effects.
No conflict of interest.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://​creativecommons.​org/​licenses/​by/​4.​0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Metadaten
Titel
EHMTI-0318. The place of corticosteroids in migraine attack management: systematic review and critical appraisal
verfasst von
YW Woldeamanuel
AM Rapoport
RP Cowan
Publikationsdatum
01.12.2014
Verlag
Springer Milan
Erschienen in
The Journal of Headache and Pain / Ausgabe Sonderheft 1/2014
Print ISSN: 1129-2369
Elektronische ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-15-S1-G42

Weitere Artikel der Sonderheft 1/2014

The Journal of Headache and Pain 1/2014 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.